PspC, a pneumococcal surface protein, binds human factor H

Infection and Immunity

Volumn 69, Issue 5, 2001, Pages 3435-3437

  Dave, S ^a   Brooks Walter, A ^a   Pangburn, M K ^a   McDaniel, L S ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; MEMBRANE PROTEIN; PROTEIN PSPC; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BINDING AFFINITY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PURIFICATION; STREPTOCOCCUS PNEUMONIAE; WESTERN BLOTTING;

BACTERIAL PROTEINS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; COMPLEMENT FACTOR H; HUMANS; PROTOZOAN PROTEINS;

EID: 0035061045     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.5.3435-3437.2001     Document Type: Article

References (17)

1. Pneumococcal diversity: Considerations for new vaccine strategies with an emphasis on pneumococcal surface protein A (PspA)
2. The pspC gene of Streptococcus pneunmoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia
3. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae
4. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component
5. Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif
6. Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types
7. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type
8. Molecular localization of variable and conserved regions of pspA, and identification of additional pspA homologus sequences in Streptococcus pneumoniae
9. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA)
10. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H
11. Human Ceb inactivator: Isolation, characterization, and demonstration of an absolute requirement for the serum protein beta-1H for cleavage of C3b and C4b in solution
12. Contribution of novel choline-binding proteins to adherence, colonization, and immunigenicity of Streptococcus pneumoniae
13. Pneumococcal disease: Prospects for a new generation of vaccines
14. C3 as substrate for adhesion of Streptococcus pneumoniae
15. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae
16. Analysis of pneumococcal PspA microheterogeneity in SDS polyacrylamide gels and the association of PspA with the cell membrane
17. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae